203 related articles for article (PubMed ID: 10214859)
1. The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression.
Rooke HM; Vitas MR; Crosier PS; Crosier KE
Leukemia; 1999 Apr; 13(4):535-41. PubMed ID: 10214859
[TBL] [Abstract][Full Text] [Related]
2. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
Carethers JM; Pham TT
In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
[TBL] [Abstract][Full Text] [Related]
3. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.
Gaiger A; Henn T; Hörth E; Geissler K; Mitterbauer G; Maier-Dobersberger T; Greinix H; Mannhalter C; Haas OA; Lechner K; Lion T
Blood; 1995 Sep; 86(6):2371-8. PubMed ID: 7662984
[TBL] [Abstract][Full Text] [Related]
4. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
5. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas.
Izumoto S; Arita N; Ohnishi T; Hiraga S; Taki T; Tomita N; Ohue M; Hayakawa T
Cancer Lett; 1997 Jan; 112(2):251-6. PubMed ID: 9066736
[TBL] [Abstract][Full Text] [Related]
7. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
8. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
[TBL] [Abstract][Full Text] [Related]
9. Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia.
Li Z; Luo J
Biochem Biophys Res Commun; 2018 Jun; 501(1):64-72. PubMed ID: 29704505
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
11. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
Tanaka K; Takauchi K; Takechi M; Kyo T; Dohy H; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):317-22. PubMed ID: 8049652
[TBL] [Abstract][Full Text] [Related]
12. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.
Mori N; Morosetti R; Spira S; Lee S; Ben-Yehuda D; Schiller G; Landolfi R; Mizoguchi H; Koeffler HP
Blood; 1998 Nov; 92(9):3405-9. PubMed ID: 9787180
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability.
Akiyama Y; Iwanaga R; Ishikawa T; Sakamoto K; Nishi N; Nihei Z; Iwama T; Saitoh K; Yuasa Y
Cancer; 1996 Dec; 78(12):2478-84. PubMed ID: 8952554
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.
Markowitz S; Wang J; Myeroff L; Parsons R; Sun L; Lutterbaugh J; Fan RS; Zborowska E; Kinzler KW; Vogelstein B
Science; 1995 Jun; 268(5215):1336-8. PubMed ID: 7761852
[TBL] [Abstract][Full Text] [Related]
15. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R
Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012
[TBL] [Abstract][Full Text] [Related]
16. A novel missense mutation and frameshift mutations in the type II receptor of transforming growth factor-beta gene in sporadic colon cancer with microsatellite instability.
Orimo H; Ikejima M; Nakajima E; Emi M; Shimada T
Mutat Res; 1998 May; 382(3-4):115-20. PubMed ID: 9691992
[TBL] [Abstract][Full Text] [Related]
17. Mutation and methylation analysis of the transforming growth factor beta receptor II gene in polycythaemia vera.
Li J; Bench AJ; Huntly BJ; Green AR
Br J Haematol; 2001 Dec; 115(4):872-80. PubMed ID: 11843821
[TBL] [Abstract][Full Text] [Related]
18. Specific antisense oligomer anti Bcr-abl junctions in chronic myeloid leukemia: a cell cycle analysis and CFU-GM study.
Mahon FX; Belloc F; Vianes I; Barbot C; Boiron JM; Cowen D; Lacombe F; Brizard A; Bilhou-Nabera C; Bernard P
Leuk Lymphoma; 1995 Nov; 19(5-6):423-9. PubMed ID: 8590842
[TBL] [Abstract][Full Text] [Related]
19. BCL11A expression in acute phase chronic myeloid leukemia.
Yin J; Zhang F; Tao H; Ma X; Su G; Xie X; Xu Z; Zheng Y; Liu H; He C; Mao ZJ; Wang Z; Chang W; Gale RP; Wu D; Yin B
Leuk Res; 2016 Aug; 47():88-92. PubMed ID: 27285855
[TBL] [Abstract][Full Text] [Related]
20. Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.
Kang SH; Won K; Chung HW; Jong HS; Song YS; Kim SJ; Bang YJ; Kim NK
Int J Cancer; 1998 Aug; 77(4):620-5. PubMed ID: 9679767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
